Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Galantamine Prolonged-Release Formulation in the Treatment of Mild to Moderate Alzheimer’s Disease

Published:2005 Issue:2-3 Volume:20 Page:120-132
ISSN:1420-8008
Container-title:Dementia and Geriatric Cognitive Disorders
language:en
Short-container-title:Dement Geriatr Cogn Disord

Author:

Brodaty Henry,Corey-Bloom Jody,Potocnik Felix C.V.,Truyen Luc,Gold Michael,Damaraju Chandrasekhar Rao V.

Publisher

S. Karger AG

Subject

Psychiatry and Mental health,Cognitive Neuroscience,Geriatrics and Gerontology

Reference29 articles.

1. Alzheimer's Disease International: Global impact of dementia. Alzheimer Dis Int, 2002; available at: http://www.alz.co.uk/global/.

2. The cholinergic hypothesis of Alzheimer's disease: a review of progress

3. Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

4. Nicotinic receptor modulation: Advantages for successful Alzheimer’s disease therapy

5. Treatment of dementia with neurotransmission modulation

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s disease and its treatment–yesterday, today, and tomorrow;Frontiers in Pharmacology;2024-05-24

2. Evaluating the efficacy and safety of Alzheimer’s disease drugs: A meta-analysis and systematic review;Medicine;2024-04-19

3. The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs;International Journal of Surgery;2024-04-03

4. Small Peptides Targeting BACE-1, AChE, and A-β Reversing Scopolamine-Induced Memory Impairment: A Multitarget Approach against Alzheimer’s Disease;ACS Omega;2024-03-04

5. Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer’s disease: A systematic review and meta-analysis;Advances in Clinical and Experimental Medicine;2024-03-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3